Andrew I. Koven
CIK: 0001258673
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)3 (100.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
About KOVEN ANDREW I
KOVEN ANDREW I (SEC CIK 0001258673) files insider reports with the SEC as Director of MetaVia Inc. (MTVA) and Director of KALA BIO, Inc. (KALA).
Signal8 holds 3 ownership filings by KOVEN ANDREW I, all Form 4s, filed between Jun 17, 2025 and Jun 8, 2026. Those filings report 3 transactions, from Jun 15, 2025 to Jun 8, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on KOVEN ANDREW I's filings is in CAMBRIDGE, MA.
Recent filings by KOVEN ANDREW I
Other insiders filing for MetaVia Inc. (MTVA)
- Browne Sarah Kaplan, Chief Medical Officer
- Tursi James Patrick, Director
- STRICKLAND D GORDON, Director
- Salsbury Michael, Director
- GROVES JASON L, Director
- Glickman Mark A, Director